iHealthScreen receives US patent for AI-based glaucoma detection model
Click Here to Manage Email Alerts
The AI-based software startup company iHealthScreen has been awarded a U.S. patent for its iPredict glaucoma detection system, the company announced in a press release.
The platform uses high-resolution images of the eye and retina taken via a color fundus camera and provides a fully automated glaucoma detection report in less than 60 seconds with 94.3% accuracy, the release stated. Results will indicate whether a patient needs to be referred to a glaucoma specialist.
iHealthScreen founder and CEO Alauddin Bhuiyan, PhD, told Healio that optometrists will be able to “use this for everyone who walks in to your practice as initial screening.” The system also can be implemented in primary care settings for early glaucoma detection.
According to the release, the company has other AI-based screening tools to detect diabetic retinopathy and age-related macular degeneration, which have been approved in the U.K. and Australia.
Collapse
Press Release
Click Here to Manage Email Alerts